Immuneering Corporation is a biopharmaceutical company with a pipeline focusing on improving patient outcomes across a spectrum of oncologic and neurologic diseases by applying its bioinformatics to every stage of the drug development process. It provides bioinformatics and generates insights into drug mechanisms of action and patient treatment responses. The company was incorporated in 2008 and is based in Cambridge, Massachusetts.